Accounting inconsistencies call Marrone BioInnovations' recent success into question

On September 3, 2014, Marrone announced an internal investigation of the company's financial records, citing an irregularity with its Q4 2013 records and irregularities around one transaction representing $870,000 in reported revenue. In the year prior to the announcement, the company's stock had...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Infarm raises $100 million to diversify its produce

News Commentary | March 09, 2021

Building on a $170 million round in September 2020, this investment from Hanaco Ventures and Atomico brings Infarm's total funding to over $400 million. Infarm will use the funding to diversify its crop production beyond leafy greens to include mushrooms, tomatoes, and chilies. Vertical farming ... To read more, click here.

Organic and non-GMO acreage surges in the U.S. despite pandemic

News Commentary | November 16, 2021

Consumer preference for organic and non‑genetically‑modified‑organism (GMO)‑certified products is on the rise. From 2020 to 2021, the total acreage under organic farming increased by 5.5%, from 8.8 million to 9.3 million, while organic field crop acreage grew by 7.1%. A similar trend is seen in non‑... Not part of subscription

NuCicer raises USD 4.5 million to commercialize high-protein chickpea variety

News Commentary | March 09, 2022

Plant genetics startup NuCicer announced a USD 4.5 million fundng round led by Lever VC. The University of California – Davis spinout controls significant chickpea genetics and has developed a trait that increases protein content by 75%. The funds will be used for commercialization trials and ... Not part of subscription